Purpose <p>Infertility affects about 15% of couples globally, with genetic factors contributing significantly. Advances in genomic technologies have led to the discovery of genes like <i>MEI1</i>, which play a crucial role in meiosis. However, the population prevalence and pathological mechanisms of human <i>MEI1</i> variants remains poorly defined.</p> Methods <p>To elucidate the contribution of <i>MEI1</i> to spermatogenic failure, initial screening for biallelic mutations was conducted in 626 non-obstructive azoospermia (NOA) patients, followed by targeted screening for heterozygous variants in a validation cohort comprising 1,607 well-characterized idiopathic male infertility cases (626 NOA, 799 severe oligoasthenospermia, and 182 terato/asthenozoospermia).</p> Results <p>Here, we identify <i>MEI1</i> as a prominent gene associated with non-obstructive azoospermia (NOA), with biallelic pathogenic variants in <i>MEI1</i> were identified in 12 individuals (1.9%, 12/626). Furthermore, heterozygous <i>MEI1</i> mutations were identified in 28 patients (0.17%, 28/1607) from the broader infertility screening cohort implicate <i>MEI1</i> in a wider phenotypic spectrum, broadening its clinical relevance. Critically, micro-TESE uniformly showed no sperm retrieval in individuals carrying biallelic <i>MEI1</i> mutations, underscoring the imperative for preemptive genetic screening to avoid unnecessary surgical interventions. Mechanistically, these mutations disrupted interactions with key meiotic proteins (ANKRD31, IHO1, REC114, MEI4) in co-immunoprecipitation assays.</p> Conclusion <p>These results not only elucidate its essential function in meiosis and DSB formation but also support its potential as a molecular marker for non-invasive diagnosis.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

A common cause of non-obstructive azoospermia: biallelic MEI1 variants and implications for infertility diagnostics

  • Chen Tan,
  • Tiantian Wang,
  • Chaofeng Tu,
  • Chunbo Xie,
  • Zixu Chen,
  • Shimin Yuan,
  • Tongyao Hu,
  • Wenbin He,
  • Yong Li,
  • Yurong Wang,
  • Chen Luo,
  • Qianjun Zhang,
  • Hongchuan Nie,
  • Huan Zhang,
  • Guangxiu Lu,
  • Ge Lin,
  • Yue-Qiu Tan,
  • Lanlan Meng,
  • Juan Du

摘要

Purpose

Infertility affects about 15% of couples globally, with genetic factors contributing significantly. Advances in genomic technologies have led to the discovery of genes like MEI1, which play a crucial role in meiosis. However, the population prevalence and pathological mechanisms of human MEI1 variants remains poorly defined.

Methods

To elucidate the contribution of MEI1 to spermatogenic failure, initial screening for biallelic mutations was conducted in 626 non-obstructive azoospermia (NOA) patients, followed by targeted screening for heterozygous variants in a validation cohort comprising 1,607 well-characterized idiopathic male infertility cases (626 NOA, 799 severe oligoasthenospermia, and 182 terato/asthenozoospermia).

Results

Here, we identify MEI1 as a prominent gene associated with non-obstructive azoospermia (NOA), with biallelic pathogenic variants in MEI1 were identified in 12 individuals (1.9%, 12/626). Furthermore, heterozygous MEI1 mutations were identified in 28 patients (0.17%, 28/1607) from the broader infertility screening cohort implicate MEI1 in a wider phenotypic spectrum, broadening its clinical relevance. Critically, micro-TESE uniformly showed no sperm retrieval in individuals carrying biallelic MEI1 mutations, underscoring the imperative for preemptive genetic screening to avoid unnecessary surgical interventions. Mechanistically, these mutations disrupted interactions with key meiotic proteins (ANKRD31, IHO1, REC114, MEI4) in co-immunoprecipitation assays.

Conclusion

These results not only elucidate its essential function in meiosis and DSB formation but also support its potential as a molecular marker for non-invasive diagnosis.